AMGN vs DGX
By Alex · Tickerpine
Amgen Inc. vs Quest Diagnostics Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | DGX |
|---|---|---|
| Price | $358.33 | $209.88 |
| Market cap | $193.39B | $23.23B |
| P/E ratio | 24.9 | 23.2 |
| ROE | 101.32% | 14.54% |
| Profit margin | 20.96% | 9.08% |
| Revenue growth | 5.80% | 9.20% |
| Dividend yield | 2.81% | 1.64% |
| Beta | 0.42 | 0.59 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs DGX in plain English
- AMGN is the bigger company — about 8.3× the market cap of DGX.
- DGX is cheaper on earnings (P/E 23.2 vs 24.9).
- AMGN earns a higher return on equity (101% vs 15%).
- DGX is growing revenue faster (9% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 1.64%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
DGX return calculator
See what $1,000 in Quest Diagnostics Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.